IPPRA / Grant Monitor

2026-07-07
← Board

Limited Competition: Clinical and Translational Science Award (CTSA) Program: Collaborative and Innovative Acceleration Award (UG3/UH3 Clinical Trial Optional)

PAR-25-296 · National Institutes of Health

biomedical clinical ai data science computing communications education workforce Health Income Security and Social Services

Closes
2027-10-19 · 469 d
Award ceiling
$650,000
Award floor
Program funding
$650,000
Expected awards
Cost sharing
No
Posted
2024-12-11
Instrument
Cooperative Agreement
Characterization · gpt-5.4-mini · 2026-07-07

This award funds investigator-initiated collaborative development, demonstration, and dissemination of innovative translational science approaches, technologies, resources, or models for the CTSA Program Consortium and beyond.

Funds
applied research
University
direct
social behavioral
minor
physical sciences
minor
engineering
substantial
life biomedical
central
computational data
substantial

⚑ Limited competition: see NOFO for additional eligibility criteria beyond the notice text. · Foreign organizations are not eligible; non-domestic components of U.S. organizations are not eligible. · Cooperative agreement mechanism (substantial NIH programmatic involvement may apply). · Clinical trial optional.

Unit fits — one characterization, each unit's own rules

Physical Sciences & Engineering (demo) 80 strong technical depth: substantial; funds applied research
IPPRA 56 good outside portfolio topics; signature methods: community engaged, policy analysis; social/behavioral work is minor; funds applied research; biomedical core — IPPRA health lane is communication/crisis/policy (capped)
Tom Love Innovation Hub 45 partial funds applied research; prototyping/demonstration stage; deep-tech content

Description

The CTSA Collaborative and Innovative Acceleration Award (CCIA) aims to accelerate the pace of translational research by supporting the collaborative development, dissemination, and sustainable implementation of innovative solutions across the CTSA Program Consortium and beyond. This Notice of Funding Opportunity (NOFO) invites investigator-initiated applications to develop, demonstrate, and disseminate innovative new approaches, technologies, resources, or models that increase the impact of research across diseases, transform the field of translational science, and bring more treatments for all people more quickly.

Eligibility

Other Eligible Applicants include the following: See NOFO for further eligibility criteria.

Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply.

Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.

Apply

View on Grants.gov → CONTACT: National Institutes of Health <grantsinfo@nih.gov>

Proposal brief SEE AN EXAMPLE →

A one-page internal memo: fit assessment, submission requirements, document scaffold, and next steps dated back from the deadline — tailored to your project idea if you add one.

ONE LLM CALL (~1¢) · CACHED · REQUIRES STAFF KEY

Proposal shell · National Institutes of Health conventions SEE AN NIH EXAMPLE →

Funder-faithful document skeletons — National Institutes of Health's document set with section headings, page limits, reviewer guidance, and writing prompts; add a project idea to get [DRAFT] starter bullets. Download as .md for Word or Overleaf.

ONE LLM CALL (~2-3¢) · CACHED · SCAFFOLDING, NOT GHOSTWRITING